Serum Institute of India in Process of Seeking Emergency Covid-19 Vaccine Approval, Says CEO Adar Poonawalla 

 
Poonawalla said that his company, which is manufacturing Covishield, a Covid-19 vaccine made with a master seed from Oxford-AstraZeneca, is in the process of applying for emergency use authorization (EUA) from the country's drug regulator.